SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
$49.12 -2.13 (-4.1561%)
Analysed SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) News Sources
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know
18-04-2026
yahoo.com
3 Unprofitable Stocks We Think Twice About
14-04-2026
yahoo.com
1 Cash-Producing Stock to Consider Right Now and 2 Facing Headwinds
13-04-2026
yahoo.com
Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year
27-03-2026
fool.com
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
12-03-2026
yahoo.com
Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One Year Rally?
03-03-2026
yahoo.com
Supernus Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
25-02-2026
moby.co
Supernus Pharmaceuticals Q4 Earnings Call Highlights
25-02-2026
marketbeat.com
Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...
25-02-2026
yahoo.com
Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
25-02-2026
yahoo.com
What is the current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is $49.12.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is $-2.13.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is -4.1561%.
What is the most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is 52 out of 100.
What is the most recent average sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is .
SEC-8K** Filing Available For SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.